Ziefen, Switzerland

Tanja Schulz-Gasch

USPTO Granted Patents = 33 

 

 

Average Co-Inventor Count = 6.4

ph-index = 7

Forward Citations = 143(Granted Patents)


Location History:

  • Liestal, CH (2007 - 2014)
  • Ziefen, CH (2012 - 2019)

Company Filing History:


Years Active: 2007-2019

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Certainly, here is the article about inventor Tanja Schulz-Gasch:

Title: The Innovative Mind of Tanja Schulz-Gasch

Introduction:

Tanja Schulz-Gasch, a prolific inventor hailing from Ziefen, Switzerland, has made a significant mark in the field of pharmaceuticals with an impressive portfolio of 33 patents to his name. His groundbreaking work in developing novel compounds for medicinal purposes has revolutionized the landscape of viral disease treatment.

Latest Patents:

Among his latest patents, Tanja Schulz-Gasch has introduced Pyridine derivatives, presenting a compound with formula (I) that exhibits promising potential as a medicament. Additionally, his invention of Cap/endo dual inhibitors, represented by a compound with general formula (V), has opened avenues for more effective treatment, amelioration, or prevention of viral diseases through specific combination therapies.

Career Highlights:

During his career, Tanja Schulz-Gasch has contributed significantly to the research and development efforts of renowned pharmaceutical companies, including Hoffmann-La Roche Inc. His relentless pursuit of innovation and scientific excellence has led to the successful translation of his ideas into tangible solutions that benefit society at large.

Collaborations:

Tanja Schulz-Gasch has had the privilege of collaborating with esteemed professionals in the field, such as Matthias Heinrich Nettekoven and Uwe Grether. Through synergistic teamwork and shared expertise, these collaborations have resulted in the creation of pioneering pharmaceutical products that have the potential to redefine the standard of care in viral disease management.

Conclusion:

In conclusion, Tanja Schulz-Gasch epitomizes the essence of a visionary inventor who continuously pushes the boundaries of scientific discovery in the realm of pharmaceuticals. His dedication to advancing healthcare through innovative solutions serves as an inspiration to aspiring inventors and researchers worldwide, leaving an indelible impact on the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…